Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > Hmmm
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Investandprayon Mar 19, 2010 3:09pm
388 Views
Post# 16904265

RE: Hmmm

RE: Hmmm

   And to have it on a friday when fridays are usually a quiet day. I would suspect the announcement comes Monday or Tuesday or sometime next week. It could also be people realizing the 60 day period is coming up when FDA is supposed to advise of their prority review. I'm hoping for a Yes. Why would they grant fast track status and then not give priority review? It would not make sense to say no. I think you have a safe bet macbethorfaust.  
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities